Bibliography
Found 95 results
Filters: Keyword is Brain [Clear All Filters]
HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis. PLoS Biol. 2020 ;18(5):e3000660.
. Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults. J Neurovirol. 2019 ;25(6):741-753.
. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain. 2019 ;142(3):502-511.
. Effects of comorbidity burden and age on brain integrity in HIV. AIDS. 2019 ;33(7):1175-1185.
Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy. J Neuroimmune Pharmacol. 2019 ;14(1):110-119.
. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia. Neurobiol Dis. 2019 ;130:104502.
No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complications. Arch Virol. 2019 ;164(2):473-482.
. Overexpression and activation of colony-stimulating factor 1 receptor in the SIV/macaque model of HIV infection and neuroHIV. Brain Pathol. 2019 ;29(6):826-836.
. Risk of developing cerebral β-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 ;33(14):2157-2166.
. Sigma-1 Receptor Antagonist (BD1047) Decreases Cathepsin B Secretion in HIV-Infected Macrophages Exposed to Cocaine. J Neuroimmune Pharmacol. 2019 ;14(2):226-240.
. Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals. J Neurovirol. 2018 ;24(5):629-637.
. Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018 ;32(14):2005-2015.
. Brain Large Artery Lymphocytic Inflammation and Human Immunodeficiency Virus-Related Brain Arterial Remodeling. J Virol. 2018 ;92(12).
. Brain vascular intima vulnerability among HIV-positive and negative individuals. AIDS. 2018 ;32(15):2209-2216.
. Brain-specific HIV Nef identified in multiple patients with neurological disease. J Neurovirol. 2018 ;24(1):1-15.
. Diffusion Kurtosis Imaging Shows Similar Cerebral Axonal Damage in Patients with HIV Infection and Multiple Sclerosis. J Neuroimaging. 2018 ;28(3):320-327.
. Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection. J Neuroinflammation. 2018 ;15(1):70.
. A neuropathologic diagnosis of Alzheimer's disease in an older adult with HIV-associated neurocognitive disorder. Neurocase. 2018 ;24(4):213-219.
. The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection. J Neuroimaging. 2018 ;28(2):217-224.
. When do models of NeuroAIDS faithfully imitate "the real thing"?. J Neurovirol. 2018 ;24(2):146-155.
. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis. 2017 ;17(1):151.
. Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation. Antimicrob Agents Chemother. 2017 ;61(1).
. Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging. Stroke. 2017 ;48(3):638-644.
. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol. 2017 ;91(20).
. Improvements in brain and behavior following eradication of hepatitis C. J Neurovirol. 2017 ;23(4):593-602.